For research use only. Not for therapeutic Use.
MDH1-IN-1 (Compound 5i) is a potent inhibitor of MDH1 with an IC50 of 6.79 μM. MDH1-IN-1 has the potential for the research of cancer diseases[1].
Catalog Number | I043650 |
CAS Number | 2143463-31-2 |
Synonyms | methyl 3-[[2-(4-pentylphenoxy)acetyl]amino]benzoate |
Molecular Formula | C21H25NO4 |
Purity | ≥95% |
InChI | InChI=1S/C21H25NO4/c1-3-4-5-7-16-10-12-19(13-11-16)26-15-20(23)22-18-9-6-8-17(14-18)21(24)25-2/h6,8-14H,3-5,7,15H2,1-2H3,(H,22,23) |
InChIKey | HDBDOZJTIIABKV-UHFFFAOYSA-N |
SMILES | CCCCCC1=CC=C(C=C1)OCC(=O)NC2=CC=CC(=C2)C(=O)OC |
Reference | [1]. Naik R, et al. Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism. J Med Chem. 2017;60(20):8631-8646. |